Racanelli, Vito
 Distribuzione geografica
Continente #
EU - Europa 588
AS - Asia 448
NA - Nord America 422
SA - Sud America 3
AF - Africa 2
OC - Oceania 1
Totale 1.464
Nazione #
US - Stati Uniti d'America 420
SG - Singapore 356
IT - Italia 261
DE - Germania 219
ID - Indonesia 62
RU - Federazione Russa 29
FI - Finlandia 24
CN - Cina 20
SE - Svezia 12
GB - Regno Unito 11
IE - Irlanda 10
CZ - Repubblica Ceca 6
NL - Olanda 5
FR - Francia 3
IN - India 3
AO - Angola 2
CA - Canada 2
EC - Ecuador 2
IQ - Iraq 2
LV - Lettonia 2
RS - Serbia 2
AR - Argentina 1
AT - Austria 1
AU - Australia 1
BE - Belgio 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
PH - Filippine 1
PT - Portogallo 1
TH - Thailandia 1
TR - Turchia 1
Totale 1.464
Città #
Singapore 230
Columbus 228
Trento 112
Jakarta 62
Toenisvorst 49
Dallas 34
Uhlingen-Birkendorf 31
Santa Clara 30
Moscow 22
Rome 19
Lappeenranta 18
Lavis 16
Milan 16
New York 15
Bari 13
Ashburn 12
Bassano del Grappa 11
Dublin 10
Springfield 7
Brno 6
Fort Worth 6
Helsinki 6
Munich 6
Trieste 5
Los Angeles 4
Amsterdam 3
Bad Vilbel 3
Kent 3
Marzabotto 3
Milwaukee 3
Modugno 3
Padova 3
Palermo 3
Southwark 3
Turin 3
Wandsworth 3
Beijing 2
Bochum 2
Bologna 2
Castelfranco Veneto 2
Council Bluffs 2
Genoa 2
Hillah 2
Hyderabad 2
Kilburn 2
Mugnano di Napoli 2
Newark 2
Ngola 2
Paris 2
Pomarolo 2
Prineville 2
Riga 2
Shanghai 2
Shenzhen 2
Smederevo 2
Terre Haute 2
Umeå 2
Venice 2
Vicenza 2
Ancona 1
Bishkek 1
Brescia 1
Buenos Aires 1
Casale Corte Cerro 1
Cernusco sul Naviglio 1
Chengdu 1
Fayetteville 1
Foshan 1
Frankfurt am Main 1
Gatchina 1
Haifa 1
Istanbul 1
Jiangmen 1
Kolkata 1
London 1
Manila 1
Nanto 1
Nuremberg 1
Pasadena 1
Perm 1
Prescot 1
St Petersburg 1
Staten Island 1
Stockholm 1
Toronto 1
Vienna 1
Voronezh 1
Washington 1
Xiamen 1
Zhengzhou 1
Zhongshan 1
Totale 1.079
Nome #
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) 219
Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations 34
Adipose failure through adipocyte overload and autoimmunity 29
Predicting Factors of Worse Prognosis in COVID-19: Results from a Cross-sectional Study on 52 Inpatients Admitted to the Internal Medicine Department 26
Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes 23
Corrigendum: Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals 23
Carcinogenesis and Metastasis in Liver: Cell Physiological Basis 20
Impact of belimumab therapy on the quality of life in patients with systemic lupus erythematosus: A cohort study 19
The emerging role of noncoding RNAs in systemic lupus erythematosus: new insights into the master regulators of disease pathogenesis 18
CT pulmonary angiography appropriateness in a single emergency department: does the use of revised Geneva score matter? 18
Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): Similarities, differences and the role of autoimmunity 18
Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma 17
Anti-COVID-19 Vaccination in Patients with Autoimmune-Autoinflammatory Disorders and Primary/Secondary Immunodeficiencies: The Position of the Task Force on Behalf of the Italian Immunological Societies 17
Application of average volume assured pressure support (AVAPS) and ultrasound assessment in COVID-19 infection: real-life observation 17
Prognostic role of neoplastic markers in Takotsubo syndrome 17
Hepatocellular Carcinoma Intrinsic Cell Death Regulates Immune Response and Prognosis 17
Arginase 1 (Arg1) as an Up-Regulated Gene in COVID-19 Patients: A Promising Marker in COVID-19 Immunopathy 16
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 16
Actors on the Scene: Immune Cells in the Myeloma Niche 16
A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery 15
Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study 15
Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions 15
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? 15
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery 15
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 15
Classic pyoderma gangrenosum 15
EARLY ECHOCARDIOGRAPHIC DETECTION OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS ASYMPTOMATIC FOR CARDIOVASCULAR DISEASE 15
Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche 15
INTERACTION OF JUNCTIONAL ADHESION MOLECULES IN THE BONE MARROW-NICHE: MICE MODEL AND CLINICAL IMPACT FOR MULTIPLE MYELOMA PATIENTS 14
Cutaneous polyarteritis nodosa and pulmonary arterial hypertension: An unexpected liaison. A case report 14
Editorial: Targeting antigen processing and presentation in autoimmune and autoinflammatory disorders 14
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 14
Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs 14
HB-EGF–EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma 14
The Importance of Real-World Data in Evaluating the Safety of Biosimilars: A Descriptive Study of Clinical Practice in an Oncohematological Italian Population 14
Non-Classical HLA Class 1b and Hepatocellular Carcinoma 14
Identification and monitoring of Copy Number Variants (CNV) in monoclonal gammopathy 14
Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals 14
Exploiting systems biology to investigate the gene modules and drugs in ovarian cancer: A hypothesis based on the weighted gene co-expression network analysis 13
Concurrent chromothripsis events in a case of TP53 depleted acute myeloid leukemia with myelodysplasia-related changes 13
Endothelial cells in tumor microenvironment: insights and perspectives 13
Electrocardiographic Pathological Findings Caused by the SARS-CoV-2 Virus Infection: Evidence from a Retrospective Multicenter International Cohort Longitudinal Pilot Study of 548 Subjects 13
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 13
Targeting the dynamic transcriptional landscape of Treg subpopulations in pancreatic ductal adenocarcinoma: Insights from single-cell RNA sequencing analysis with a focus on CTLA4 and TIGIT 13
Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice 13
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 13
Cytotoxic t-lymphocyte antigen-4 in colorectal cancer: Another therapeutic side of capecitabine 13
The Role of Hemoglobin Subunit Delta in the Immunopathy of Multiple Sclerosis: Mitochondria Matters 13
Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients 13
From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting the Lessons From the Past 13
Deciphering the immune landscape of head and neck squamous cell carcinoma: A single-cell transcriptomic analysis of regulatory T cell responses to PD-1 blockade therapy 13
Lupus vasculitis: An overview 13
Impact of Antigen Presentation Mechanisms on Immune Response in Autoimmune Hepatitis 13
COVID-19 and the Endocrine System: A Comprehensive Review on the Theme 13
Tumor necrosis factor‑α in systemic lupus erythematosus: Structure, function and therapeutic implications (Review) 12
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 12
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials 12
Systemic Lupus Erythematosus therapy: new possibilities since 50 years 12
The worldwide impact of COVID-19 on cancer care: A meta-analysis of surveys published after the first wave of the pandemic 12
MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A RETROSPECTIVE REAL-WORLD EUROPEAN STUDY ON 142 PATIENTS 12
AMYLOID HEART INVOLVEMENT LEAD A FAST FATAL EVOLUTION IN A HEALTHY WOMAN: A CASE REPORT 12
Weighted Gene Co-Expression Network Analysis Combined with Machine Learning Validation to Identify Key Modules and Hub Genes Associated with SARS-CoV-2 Infection 12
Bone marrow endothelial cells of patients with multiple myeloma: antigen presenting functions and T cell regulation 12
Unraveling the Role of Peroxisome Proliferator-Activated Receptor β/Δ (PPAR β/Δ) in Angiogenesis Associated with Multiple Myeloma 12
18F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders 12
Regulation of ctla-4 and pd-l1 expression in relapsing-remitting multiple sclerosis patients after treatment with fingolimod, ifnβ-1α, glatiramer acetate, and dimethyl fumarate drugs 12
A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target 11
PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases 11
PROSTETIC AMICROBIAL ENDOCARDITIS REVEALED HEART INVOLVEMENT IN SYSTEMIC LUPUS ERITHEMATOSUS (SLE): A CASE REPORT 11
Early administration of tofacitinib in COVID ‐19 pneumonitis: An open randomised controlled trial 11
Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy 11
Single-cell RNA sequencing uncovers heterogeneous transcriptional signatures in tumor-infiltrated dendritic cells in prostate cancer 11
Spotlight on Cardiovascular Scoring Systems in Covid-19: Severity Correlations in Real-world Setting 11
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 11
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 11
The expression pattern of VISTA in the PBMCs of relapsing-remitting multiple sclerosis patients: A single-cell RNA sequencing-based study 11
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside 11
T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies 11
Two structurally different rituximab-specific CD20 mimotope peptides reveal that rituximab recognizes two different CD20-associated epitopes 11
The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead 10
Corona Virus Disease 19 (CoViD-19) impact on cardiovascular disease in a non-CoViD-19 emergency setting 10
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial? 10
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 10
Idiopathic nonhistaminergic angioedema: A single-center real-life experience from Italy 10
Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis 10
Galectin-3 and neutrophil-to-lymphocyte ratio are indicative of heart remodelling and disease severity in patients with obstructive sleep apnoea 10
VASCULITI NON ATEROSCLEROTICHE DI INTERESSE CHIRURGICO 10
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment 10
Cardiotoxicity Induced by Immune Checkpoint Inhibitors: What a Cardio-Oncology Team Should Know and Do 10
Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment 10
Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma 10
A spatial view of the CD8(+) T-cell response: the case of HCV 10
Antibody production and in vitro behavior of CD27-defined B-cell subsets: persistent hepatitis C virus infection changes the rules 9
Apocynin regulates cytokine production of CD8+ T cells 9
MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance 9
Long-term follow up of patients with acute hepatitis C and spontaneous resolution 9
Effectiveness and safety of belimumab in patients with active systemic lupus erythematosus: results from a large, nationwide, multicentric study 9
Age-related differences in human palatine tonsillar B cell subsets and immunoglobulin isotypes 9
Infectivity of donations from eclipse and ramp-up stages of HCV infection in chimpanzees 9
Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma 9
Totale 1.552
Categoria #
all - tutte 18.261
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 320
Totale 18.581


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20241.030 0 167 89 212 9 42 136 85 58 58 70 104
2024/2025821 40 82 135 459 105 0 0 0 0 0 0 0
Totale 1.851